|
Age, <40/40-59/60≤
|
7/22/10
|
18/56/26
|
22/23/10
|
40/42/18
|
0.07
|
|
Age (y/o)
|
50.0 ± 11.8
|
44.3 ± 14.5
|
0.03
|
|
Gender, female/male
|
11/28
|
28/72
|
18/37
|
33/67
|
0.7
|
|
Drug, LAM/ETV
|
25/14
|
64/36
|
38/17
|
69/31
|
0.7
|
|
ALT (IU/L), <100/100-199/200≤
|
12/16/11
|
31/41/28
|
20/13/22
|
36/24/40
|
0.19
|
|
HBV-DNA (Log copy/mL), <6/6-7.6/7.6<
|
11/22/6
|
28/56/15
|
4/20/31
|
7/36/56
|
0.001
|
|
Genotype*, B/C
|
5/26
|
16/84
|
1/37
|
3/97
|
0.07
|
|
HBsAg (IU/mL)*, <1000/1000-10000/10000≤
|
7/11/5
|
30/48/22
|
3/9/8
|
15/45/40
|
0.09
|
|
Histology (METAVIR Staging)*, 1/2/3
|
13/8/6
|
48/30/22
|
11/13/7
|
35/42/23
|
0.6
|
|
Histology (METAVIR Grading)*, 1/2/3
|
7/17/3
|
26/63/11
|
8/15/8
|
26/48/26
|
0.3
|
